Uncategorized
Medicspot Mounjaro Cost
Medicspot Mounjaro Cost: Complete UK Pricing Guide 2024
Written by
Bolt Pharmacy
Published
25/11/2025
Last Updated
5/8/2026
Weight loss treatments
GLP-1 / GIP
Mounjaro
Prices from
£149.00
GLP-1
Wegovy
Prices from
£99.00
Understanding the cost of Mounjaro through Medicspot is essential for patients considering this treatment option in the UK. Mounjaro (tirzepatide) is a prescription medicine licensed for type 2 diabetes, administered as a once-weekly injection. As a private healthcare provider, Medicspot offers remote consultations and prescriptions for Mounjaro, with costs significantly higher than NHS routes. This article examines Medicspot’s pricing structure, medication costs, and ongoing monitoring expenses. We also explore how Medicspot’s service compares to NHS provision and what patients should budget for a full treatment course.
Summary: Mounjaro costs through Medicspot typically range from £1,790–£3,350 (price-comparison listing, checked 4 August 2026) annually, including initial consultations (£149–£279), monthly medication (£149–£279 per pen), and regular follow-up appointments (£149–£279 each).
- Tirzepatide is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes treatment
- NHS prescription charges are £9.90 per item in England for eligible patients meeting NICE criteria
- Private medication costs vary by dose strength from approximately £149–£279 per four-week supply
- Regular clinical monitoring is essential including baseline blood tests and quarterly reviews to assess efficacy and safety
- Current supply constraints affecting GLP-1 receptor agonists may impact availability and require prioritisation of existing patients
- Common adverse effects include gastrointestinal symptoms and contraindications exist for pregnancy and certain thyroid conditions
Table of Contents
- What Is Mounjaro and How Does It Work?
- NHS vs Private Prescriptions: Cost Comparison
- How to Access Mounjaro Through Medicspot
- Mounjaro Pricing at Medicspot: What to Expect
- Scientific References
- Frequently Asked Questions
What Is Mounjaro and How Does It Work?
Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes.[1][2] Manufactured by Eli Lilly, Mounjaro is administered as a once-weekly subcutaneous injection and has gained considerable attention for its dual mechanism of action and significant clinical efficacy.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This means it mimics the action of two naturally occurring incretin hormones that regulate blood sugar and appetite. By activating GIP receptors, Mounjaro enhances insulin secretion. Simultaneously, GLP-1 receptor activation slows gastric emptying (transiently), reduces appetite, and promotes satiety.[1][13] Together, these mechanisms lead to improved glycaemic control in people with type 2 diabetes and substantial weight loss.
In clinical trials such as the SURPASS programme, Mounjaro demonstrated significant weight reduction, with results varying by dose and patient population.[9][10] Common adverse effects include nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation.[1][2] These gastrointestinal symptoms are usually mild to moderate and tend to diminish over time.
Important safety considerations include:
- Not recommended during pregnancy or breastfeeding
- Reduced oral contraceptive absorption (additional contraception needed for 4 weeks after starting and after each dose increase)
- Risk of hypoglycaemia when used with insulin or sulfonylureas
- Potential risk of pancreatitis and gallbladder disease
- Caution in patients with diabetic retinopathy
- Risk of dehydration and acute kidney injury
In the UK, Mounjaro is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and is available through both NHS and private prescribing routes. The National Institute for Health and Care Excellence (NICE) has issued guidance on its use for type 2 diabetes. Patients considering Mounjaro should undergo a thorough medical assessment to ensure suitability and to discuss potential risks and benefits.
Currently, GLP-1 receptor agonists including tirzepatide are experiencing supply constraints in the UK, which may affect availability.
GLP-1 / GIP treatment
Mounjaro® for Weight Loss
£30 off your first order
Mounjaro is a once-weekly injection that targets both GLP-1 and GIP, helping to curb appetite, hunger, and cravings to support substantial, sustained weight loss.
- ~22.5%average body weight loss
- Significant weight reduction
- Improves blood sugar levels
- Clinically proven weight loss
Check Eligibility & Unlock £30 discount
Prescription required • Discount applied if prescribed • Online consultation
NHS vs Private Prescriptions: Cost Comparison
Access to Mounjaro in the UK varies significantly depending on whether you obtain it through the NHS or via a private prescription, with cost implications being a primary consideration for many patients.
NHS Prescriptions: Currently, Mounjaro is available on the NHS primarily for the treatment of type 2 diabetes in patients who meet specific clinical criteria outlined in NICE guidance (TA870). For those eligible, the standard NHS prescription charge in England applies—currently £9.90 per item (as of 2024), or free for patients in Scotland, Wales, and Northern Ireland, or those with valid exemption certificates. Access is typically through specialist diabetes services or GP prescribing following specialist recommendation.
NHS availability is subject to current supply constraints affecting GLP-1 receptor agonists, with NHS England providing guidance on prioritisation of existing patients.
Private Prescriptions: For patients seeking Mounjaro who do not meet NHS eligibility criteria, private prescriptions offer an alternative route. Private costs are substantially higher and vary between providers. Typically, patients can expect to pay in the range of £149–£279 (price-comparison listing, checked 4 August 2026) per month for Mounjaro through Medicspot. Prices shown are indicative and may have changed. Always check directly with the provider for current pricing, as costs vary depending on the dose, plan, and any ongoing promotions.
When comparing NHS and private routes, patients should consider not only cost but also eligibility criteria and the level of ongoing clinical support provided. Private services often offer more flexible appointment scheduling, which may be valuable for individuals seeking timely intervention. However, all prescribing is subject to current supply constraints and clinical appropriateness.
How to Access Mounjaro Through Medicspot
Medicspot is a UK-based digital healthcare provider offering remote consultations and private prescriptions for a range of conditions. Accessing Mounjaro through Medicspot involves a structured, clinically governed process designed to ensure patient safety and treatment appropriateness.
Step 1: Online Assessment Patients begin by completing a comprehensive online medical questionnaire on the Medicspot platform. This assessment gathers information about medical history, current medications, allergies, weight management goals, and any contraindications to GLP-1 receptor agonist therapy. The questionnaire identifies patients who may not be suitable candidates—for example, those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (where tirzepatide is not recommended).[1][2]
Step 2: Clinical Review Once submitted, the assessment is reviewed by a UK-registered prescriber (typically a GP or specialist prescribing clinician). If further information is required, the clinician may request a video or telephone consultation to discuss treatment goals, potential side effects, and realistic expectations. This consultation also provides an opportunity to review baseline measurements such as body mass index (BMI), blood pressure, and relevant blood tests (e.g., HbA1c, renal function).
Step 3: Prescription and Delivery If deemed clinically appropriate, the prescriber issues a private prescription for Mounjaro. The medication is typically dispensed by a registered UK pharmacy and delivered directly to the patient’s home via secure courier, usually within 2–5 working days. Patients receive clear instructions on:
- Injection technique and site rotation
- Dose escalation schedules
- Storage requirements
- Missed dose management
- Sharps disposal according to local council arrangements
- Need for additional contraception if using oral contraceptives
Step 4: Ongoing Monitoring Medicspot emphasises the importance of regular follow-up. Patients are encouraged to schedule reviews to monitor progress, assess tolerability, and adjust dosing as needed. Any concerning symptoms—such as severe abdominal pain, persistent vomiting, or signs of pancreatitis—should prompt immediate contact with the prescribing clinician, NHS 111, or attendance at A&E (or call 999 in emergencies).
Patients are advised to inform their NHS GP about their treatment to ensure coordinated care, particularly if they take other medications like insulin or sulfonylureas that may need dose adjustment to prevent hypoglycaemia.
It is essential to note that Medicspot operates as a private healthcare service, and all associated costs are borne by the patient.
Mounjaro Pricing at Medicspot: What to Expect
Understanding the cost structure for Mounjaro at Medicspot is crucial for patients considering this treatment pathway. As a private service, Medicspot’s pricing reflects medication costs, and ongoing clinical support.
Initial Consultation:
Medication Costs: Mounjaro is available in several dose strengths, starting at 2.5 mg and escalating to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg as tolerated. Medicspot’s Mounjaro pricing ranges from £149–£279 per month depending on the dose required. Prices shown are indicative and may have changed. Always check directly with the provider for current pricing, as costs vary depending on the dose, plan, and any ongoing promotions.
Patients typically start on the lowest dose and gradually increase every four weeks to minimise gastrointestinal side effects, following the dosing schedule in the Mounjaro Summary of Product Characteristics.[1][2]
It’s important to note that current supply constraints affecting GLP-1 receptor agonists may impact availability and potentially pricing.
Follow-Up Appointments: Medicspot recommends regular follow-up consultations—usually monthly for the first three months, then quarterly thereafter.
Additional Costs: Patients may also incur costs for baseline and monitoring blood tests (e.g, HbA1c, renal function), which can be arranged through private laboratories or, in some cases, via NHS GP services. Specific tests like amylase or lipase would only be performed if symptoms suggest pancreatitis.
Patients should also budget for sharps disposal containers and follow local council arrangements for safe disposal.
Total Estimated Cost: For a full year of treatment, patients should expect medication costs in the range of £149–£279 per month at Medicspot. Prices shown are indicative and may have changed. Always check directly with the provider for current pricing, as costs vary depending on the dose, plan, and any ongoing promotions. It is advisable to confirm all costs upfront with Medicspot and to enquire about any package deals or subscription models that may offer cost savings.
Patients should also be aware that Mounjaro is not currently covered by most private health insurance policies for weight management, though some insurers may provide partial reimbursement for diabetes treatment. Always check your policy terms and seek pre-authorisation if applicable.
If you experience any side effects from Mounjaro, report them via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).
Scientific References
- Mounjaro: INN: tirzepatide — Summary of Product Characteristics.
- Mounjaro KwikPen 2.5 mg solution for injection in pre-filled pen — SmPC.
- Mounjaro KwikPen 10 mg solution for injection in pre-filled pen — SmPC.
- MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
- Tirzepatide for treating type 2 diabetes (TA924).
- Tirzepatide for treating type 2 diabetes — Recommendations (TA924).
- Tirzepatide — British National Formulary.
- Tirzepatide — Interactions. British National Formulary.
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
- Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial.
- HbA1c reduction with tirzepatide in people with type 2 diabetes: The contribution of weight loss assessed by a mediation analysis.
- Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes.
- The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review.
- The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential.
- Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials.
- The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on absorption of oral hormonal contraceptives.
- Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease).
- Tirzepatide vs. semaglutide for obesity, glycemic control, and cardiovascular outcomes: a narrative review of clinical trials.
- NHS prescription charges from 1 May 2024.
- NHS prescription charges.
- GLP-1 medicines for weight loss and diabetes: what you need to know.
Frequently Asked Questions
How much does Mounjaro cost through Medicspot compared to the NHS?
NHS prescriptions cost £9.90 per item in England for eligible patients, whilst Medicspot’s private service costs approximately £1,790–£3,350 (price-comparison listing, checked 4 August 2026) annually including consultations, medication, and monitoring. NHS availability is limited to patients meeting specific NICE criteria for type 2 diabetes.
What is included in Medicspot’s Mounjaro pricing?
Medicspot’s pricing includes initial monthly medication costs (£149–£279 (price-comparison listing, checked 4 August 2026) per pen depending on dose), follow-up appointments (£149–£279 each), and may require additional costs for baseline blood tests and monitoring.
Is Mounjaro covered by private health insurance in the UK?
Mounjaro is not currently covered by most private health insurance policies for weight management, though some insurers may provide partial reimbursement for diabetes treatment. Patients should check their policy terms and seek pre-authorisation before commencing treatment.
